AD-519 neutralizing monoclonal antibody directed against the C4 region of gp120 envelope glycoprotein of HIV: Began an open-label Phase I/IIa trial under an inv

Tanox Biosystems Inc., Houston Product: AD-519 neutralizing monoclonal antibody directed against the C4 region of gp120 envelope glycoprotein of HIV Indication: Advanced HIV infection Status: Began an...